Clinical Trial Update: Spontaneous Retinal Artery Pulses (SPARs) as a Prognostic Determinant of Central Retinal Vein Occlusions (CRVO) in Patients With or Without Intravitreal Aflibercept Injections [NA]

View source ↗

Summary

A completed clinical trial examining whether spontaneous retinal artery pulses (SPARs) can prognosticate outcomes in central retinal vein occlusion, with or wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Vein Occlusion

Drugs mentioned

• EYLEA (Aflibercept)

Snippet

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild | Conditions: Central Retinal Vein Occlusion | NA | Status: COMPLETED